Katsuyama, Japan

Takaaki Mouri

This inventor holds 3 USPTO granted patents. Top assignee: Hokuriku Pharmaceutical Co., Ltd.. Active years: 1976-1979.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takaaki Mouri. Retrieved from https://idiyas.com/inventor/takaaki-mouri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Katsuyama, JA (1976)
  • Katsuyamashi, JA (1978)
  • Fukui, JP (1979)

Company Filing History:


Years Active: 1976-1979

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Takaaki Mouri: Pioneering Therapeutic Advances in Katsuyama

Introduction

Takaaki Mouri, an esteemed inventor located in Katsuyama, Japan, is recognized for his significant contributions to the field of pharmaceuticals. With a total of three patents, Mouri has played a vital role in developing innovative compounds with therapeutic applications.

Latest Patents

Mouri's latest patents include "Trimethoxyphenyl Esters of Homopiperazine-n-Monoalkanol as Vasodilators." This invention provides piperazine or homopiperazine-monoalkanol esters and their salts, prepared through the esterification of corresponding alkanol compounds. These novel compounds exhibit therapeutic activity, including analgesic, coronary vasodilative, anti-convulsant, and blood pressure-decreasing properties. Another significant patent, titled "Novel Piperazine- and Homopiperazine-Monoalkanol Esters and a Process," showcases a similar approach in which piperazine or homopiperazine-monoalkanol esters are developed for their beneficial health impacts.

Career Highlights

Mouri’s career is marked by his position at Hokuriku Pharmaceutical Co., Ltd., where he continues to enhance the organization's research and development efforts. His inventive work focuses on creating compounds that address critical health issues, thus contributing to the advancement of medical science.

Collaborations

Throughout his career, Mouri has collaborated with esteemed colleagues, including Hideo Kato and Tomoyasu Nishikawa. Their combined expertise and dedication to innovation have fostered a collaborative environment that enhances the development of significant pharmaceutical advancements.

Conclusion

Takaaki Mouri remains a notable figure in the realm of inventions, particularly in the pharmaceutical field. His innovative work not only strengthens his company, Hokuriku Pharmaceutical Co., Ltd., but also brings valuable therapeutic options to the healthcare market, demonstrating the power of innovation and collaboration in improving human health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…